ESC 365 - Targeting an altered sphingolipid profile with consecutive lipotoxicity as therapeutic approach to calcific aortic valve disease

ESC Professional Premium Access

Targeting an altered sphingolipid profile with consecutive lipotoxicity as therapeutic approach to calcific aortic valve disease

Session: Lipids and adipose tissue interaction in cardiovascular disease

Topic: Valvular Heart Disease

Speaker: Mr T. Rusack (Luebeck, DE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Mr Timo Rusack

Luebeck (Germany)

0 follower

5 more presentations in this session

Lipoprotein(a) induces spontaneous aortic dissection via increasing monocyte mediated vascular smooth muscle cell phenotype transformation in human Lp(a) transgenic mice

Speaker: Doctor C. Han (Shanghai, CN)

Lipoprotein(a) regulates vascular redox state and inflammatory response in patients with coronary artery disease

Speaker: Doctor I. Badi (Oxford, GB)

Stress memory of heart failure in hematopoietic niche promotes recurrence via adipocytic skewing of mesenchymal stromal cells

Speaker: Doctor K. Goto (Tokyo, JP)

Human epicardial adipose tissue secretome alters metabolomic profile and induces endothelial-to-mesenchymal transition in human lymphatic endothelial cells

Speaker: Doctor I. Abe (Oita, JP)

Metabolomic reprogramming of subcutaneous adipose tissue aggravates atherosclerosis via impaired adipocyte-macrophage crosstalk

Speaker: Doctor B. Lou (Xi'an, CN)

Access the full session

Lipids and adipose tissue interaction in cardiovascular disease

Speakers: Mr T. Rusack, Doctor C. Han, Doctor I. Badi, Doctor K. Goto, Doctor I. Abe...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources